Haleon plc (LON:HLN – Get Free Report)’s share price was down 0.6% during mid-day trading on Tuesday . The company traded as low as GBX 384.60 ($5.16) and last traded at GBX 388.60 ($5.22). Approximately 17,750,443 shares traded hands during mid-day trading, a decline of 32% from the average daily volume of 26,079,627 shares. The stock had previously closed at GBX 391 ($5.25).
Wall Street Analyst Weigh In
Separately, Berenberg Bank lifted their target price on Haleon from GBX 456 ($6.12) to GBX 457 ($6.14) and gave the company a “buy” rating in a research report on Friday, February 28th.
Read Our Latest Stock Analysis on HLN
Haleon Stock Down 0.6%
Insider Activity
In other news, insider Asmita Dubey purchased 15,424 shares of the business’s stock in a transaction dated Friday, May 2nd. The shares were purchased at an average cost of GBX 401 ($5.38) per share, with a total value of £61,850.24 ($83,031.60). Also, insider Blathnaid Bergin purchased 6,145 shares of the business’s stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of GBX 404 ($5.42) per share, for a total transaction of £24,825.80 ($33,327.69). Over the last three months, insiders have bought 42,869 shares of company stock valued at $17,294,104. 10.74% of the stock is currently owned by corporate insiders.
About Haleon
Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.
Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.
See Also
- Five stocks we like better than Haleon
- Best Stocks Under $10.00
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- Why Invest in High-Yield Dividend Stocks?
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- The How And Why of Investing in Oil Stocks
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.